These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Accumulation of genetic alterations and progression of primary breast cancer. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y. Cancer Res; 1991 Nov 01; 51(21):5794-9. PubMed ID: 1682035 [Abstract] [Full Text] [Related]
3. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Tsuda H, Fukutomi T, Hirohashi S. Clin Cancer Res; 1995 Mar 01; 1(3):261-7. PubMed ID: 9815981 [Abstract] [Full Text] [Related]
5. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Matsumura K, Kallioniemi A, Kallioniemi O, Chen L, Smith HS, Pinkel D, Gray J, Waldman FM. Cancer Res; 1992 Jun 15; 52(12):3474-7. PubMed ID: 1350754 [Abstract] [Full Text] [Related]
7. Loss and gain of distinct regions of chromosome 1q in primary breast cancer. Bièche I, Champème MH, Lidereau R. Clin Cancer Res; 1995 Jan 15; 1(1):123-7. PubMed ID: 9815894 [Abstract] [Full Text] [Related]
8. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S. Cancer Res; 1994 Jan 15; 54(2):513-7. PubMed ID: 8275489 [Abstract] [Full Text] [Related]
9. Genetic alteration mapping on chromosome 7 in primary breast cancer. Bièche I, Khodja A, Driouch K, Lidereau R. Clin Cancer Res; 1997 Jun 15; 3(6):1009-16. PubMed ID: 9815778 [Abstract] [Full Text] [Related]
10. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152 [Abstract] [Full Text] [Related]
11. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Filippova GN, Lindblom A, Meincke LJ, Klenova EM, Neiman PE, Collins SJ, Doggett NA, Lobanenkov VV. Genes Chromosomes Cancer; 1998 May 01; 22(1):26-36. PubMed ID: 9591631 [Abstract] [Full Text] [Related]
17. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma. Thorlacius S, Jonasdottir O, Eyfjord JE. Anticancer Res; 1991 May 01; 11(4):1501-7. PubMed ID: 1746906 [Abstract] [Full Text] [Related]
18. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Bièche I, Champème MH, Lidereau R. Cancer Res; 1994 Aug 15; 54(16):4274-6. PubMed ID: 7913873 [Abstract] [Full Text] [Related]
19. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G, Tahara E. Cancer Res; 1991 Jun 01; 51(11):2926-31. PubMed ID: 2032230 [Abstract] [Full Text] [Related]
20. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216 [Abstract] [Full Text] [Related] Page: [Next] [New Search]